Literature DB >> 23686119

Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer.

Massimo Rittà1, Vincenzo Landolfo, Jasenka Mazibrada, Marco De Andrea, Valentina Dell'Oste, Valeria Caneparo, Alberto Peretti, Carlo Giordano, Giancarlo Pecorari, Massimiliano Garzaro, Santo Landolfo.   

Abstract

The association between human papillomavirus (HPV) DNA positivity, p53 codon 72 polymorphisms, and the type of leukocyte infiltration in head and neck squamous cell carcinomas (HNSCC) and their combined impact upon patient survival is poorly investigated. For this reason, leukocyte infiltration profile and p53 codon 72 polymorphisms were assessed in freshly removed HNSCC specimens (N=71 patients). HPV detection was performed by nested-PCR followed by DNA sequencing. Viral loads were determined by quantitative RT-PCR. The choice to investigate fresh instead of archive paraffin-embedded specimens was privileged to avoid possible artifacts due to sample processing. HPV DNA was detected in 14% of cases. Oropharyngeal carcinomas were the most frequently associated with the presence of HPV16 DNA (41%) and were associated with p53 Pro/Pro or Pro/Arg polymorphisms. In HPV16-positive oropharyngeal carcinomas increased infiltrations of CD3+ and FoxP3+ T-cells correlated with higher HPV16 copy numbers. The presence of HPV may trigger a stronger immune response and may be considered a reliable marker for clinical staging and a more favorable prognosis of oropharyngeal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23686119

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  7 in total

Review 1.  TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?

Authors:  Astrid De Meulenaere; Tijl Vermassen; Sandrine Aspeslagh; Katrien Vandecasteele; Sylvie Rottey; Liesbeth Ferdinande
Journal:  Head Neck Pathol       Date:  2016-12-28

Review 2.  [Comparison of T cell response in the tumor milieu of patients with HPV+ and HPV- head and neck cancer].

Authors:  T Bastian; S Lang; B A Kansy
Journal:  HNO       Date:  2020-02       Impact factor: 1.284

3.  Biphenotypic human papillomavirus-associated head and neck squamous cell carcinoma: a report of two cases.

Authors:  Gayani Pitiyage; Mary Lei; Teresa Guererro Urbano; Edward Odell; Selvam Thavaraj
Journal:  Diagn Pathol       Date:  2015-07-11       Impact factor: 2.644

Review 4.  Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma.

Authors:  Sanne Evelien Matlung; Pauline Maria Wilhelmina van Kempen; Niels Bovenschen; Debbie van Baarle; Stefan Martin Willems
Journal:  Future Sci OA       Date:  2016-01-07

5.  Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.

Authors:  Georgia Karpathiou; Francois Casteillo; Jean-Baptiste Giroult; Fabien Forest; Pierre Fournel; Alessandra Monaya; Marios Froudarakis; Jean Marc Dumollard; Jean Michel Prades; Michel Peoc'h
Journal:  Oncotarget       Date:  2017-03-21

6.  Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Authors:  Jerome R Lechien; Imelda Seminerio; Géraldine Descamps; Quentin Mat; Francois Mouawad; Stéphane Hans; Morbize Julieron; Didier Dequanter; Thibault Vanderhaegen; Fabrice Journe; Sven Saussez
Journal:  Cells       Date:  2019-09-10       Impact factor: 6.600

Review 7.  HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas.

Authors:  Jérôme R Lechien; Géraldine Descamps; Imelda Seminerio; Sonia Furgiuele; Didier Dequanter; Francois Mouawad; Cécile Badoual; Fabrice Journe; Sven Saussez
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.